HTG Molecular

HTG Transcriptome
Panel Available Now

Simplify gene expression analysis with our new comprehensive human transcriptome panel.

Learn More
VERI/O Laboratory Services

It's not business, it's personal.
We treat our partners like colleagues and your study like our own.

Learn More
HTG EdgeSeq Panels

The most fragile RNA samples can now reveal the greatest insights for gene expression and biomarker discovery.

Learn More
HTG EdgeSeq Systems

Devlivering extraction-free RNA molecular profiling solutions and semi-automated library prep.

Learn More

Harness the Power of HTG's Proprietary Transcriptome Panel

Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG's RNA platform technologies make the development of life science tools and diagnostics more effective and cost-efficient, enabling researchers to interrogate the entire transcriptome with smaller sample requirements and higher success rates.

Featured Publication

Overview of the Design and Performance of the HTG Transcriptome Panel

This White Paper summarizes the data generated using the HTG Transcriptome Panel from Feasibility through Verification, including comparison to RNA-Seq.

READ PUBLICATION

HTG Molecular News & Events

HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention

TUCSON, Ariz. , May 18, 2023 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced that its management team will present the advantages of its proprietary drug discovery engine at the 2023…

Category:
Press Releases

Keep Reading

HTG Highlights the Advantages of Its Drug Discovery Engine

TUCSON, Ariz. , May 16, 2023 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of another technical milestone in its drug discovery business….

Category:
Press Releases

Keep Reading

HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights

TUCSON, Ariz. , May 10, 2023 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported financial results for the quarter ended March 31, 2023 and provided recent drug discovery business highlights….